The drugmaker will provide fill and finish manufacturing capacity, which will take place at its facility in Barnard Castle, England, and will begin as early as May.
GSK said it has not yet signed a detailed agreement with Novavax and the U.K. government’s COVID-19 vaccines taskforce.
The announcement is the latest example of competing drugmakers joining forces to increase the global COVID-19 vaccine supply.
More articles on pharmacy:
Moderna ships 100 millionth vaccine dose to US government
Pharma companies using tech to make drug clinical trials more diverse
J&J to deliver 11M vaccines this week
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
